Skip to content
Home / Companies / BIOA BIO
BioAge Labs, Inc. (BIOA) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest BIOA Insider Trades
About BioAge Labs, Inc. (BIOA) Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Headquarters EMERYVILLE, CA
Employees 62
Listed 2024
Exchange XNAS https://www.bioagelabs.com SEC filings for BIOA on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 2 62,566 $1.58M Grant or award 6 132,000 Option exercise 16 119,868
BIOA Insider Transactions (Form 4) 74 29 Form 4 filings on record, the earliest from Oct 1, 2024, newest first.
Date Insider Transaction Security Shares Price Value Jun 29, 2026 SB Shane Barton - Officer Option exercise Common Stock 7,261
Recent BIOA Form 8-K Filings 4
Recent BIOA Form 144 Notices of Proposed Sale 2 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jun 30, 2026 - - - - View on EDGAR Jun 29, 2026 - - -
BIOA Insider Trading - FAQ
What is the latest insider trade for BIOA? BioAge Labs, Inc. (BIOA) had 7 insider filings in the last 90 days, with the most recent on 2026-07-01. The full record for BIOA runs to 29 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BIOA stock? No insider purchases of BIOA were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling BIOA stock? 2 insider sales of BIOA were filed in the last 90 days, totaling $1.58M.
Where can I see BIOA SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks BIOA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BIOA insider buys? Create a free InsiderAlpha account and press Watch on this page to add BIOA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track BIOA insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $442.91M
P/E ratio -
Dividend yield -
Average volume 823.8K
52 week high $25.96
52 week low $4.55
Today's high $10.25
Today's low $9.60
Open $10.06
Volume 452.2K
Previous close $10.08
Shares outstanding 45.90M Market cap
$442.91M
62 employees
BIOA Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 2 sales totaling $1.58M.
Most-Active BIOA Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jun 29, 2026 SB Shane Barton - Officer Option exercise Common Stock 8,958 $4.30 $39K
Jun 29, 2026 SB Shane Barton - Officer Option exercise Common Stock 14,198 $4.38 $62K
Jun 29, 2026 SB Shane Barton - Officer Open-market sale Common Stock 42,350 $25.21 $1.07M
Jun 30, 2026 SB Shane Barton - Officer Option exercise Common Stock 4,290 $10.85 $47K
Jun 30, 2026 SB Shane Barton - Officer Option exercise Common Stock 4,000 $8.39 $34K
Jun 30, 2026 SB Shane Barton - Officer Option exercise Common Stock 4,065 $4.30 $17K
Jun 30, 2026 SB Shane Barton - Officer Option exercise Common Stock 7,861 $4.38 $34K
Jun 30, 2026 SB Shane Barton - Officer Open-market sale Common Stock 20,216 $25.19 $509K
Jun 29, 2026 SB Shane Barton - Officer Option exercise Stock Option (Right to Buy) 9,301 $0.00 -
Jun 29, 2026 SB Shane Barton - Officer Option exercise Stock Option (Right to Buy) 7,261 $0.00 -
Jun 29, 2026 SB Shane Barton - Officer Option exercise Stock Option (Right to Buy) 8,958 $0.00 -
Jun 29, 2026 SB Shane Barton - Officer Option exercise Stock Option (Right to Buy) 14,198 $0.00 -
Jun 30, 2026 SB Shane Barton - Officer Option exercise Stock Option (Right to Buy) 4,290 $0.00 -
Jun 30, 2026 SB Shane Barton - Officer Option exercise Stock Option (Right to Buy) 4,000 $0.00 -
Jun 30, 2026 SB Shane Barton - Officer Option exercise Stock Option (Right to Buy) 4,065 $0.00 -
Jun 29, 2026 SB Shane Barton - Officer Option exercise Common Stock 9,301 $10.85 $101K
Jun 30, 2026 SB Shane Barton - Officer Option exercise Stock Option (Right to Buy) 7,861 $0.00 -
Jun 10, 2026 RH Rekha Hemrajani Grant or award Stock Option (Right to Buy) 22,000 $0.00 -
Jun 10, 2026 JH James Healy Grant or award Stock Option (Right to Buy) 22,000 $0.00 -
Apr 23, 2026 DG Dov A. Md Goldstein - Officer Option exercise Stock Option (Right to Buy) 3,542 $0.00 -
Apr 1, 2026 PR Paul D. Rubin - Officer Option exercise Common Stock 5,437 $4.11 $22K
Apr 1, 2026 PR Paul D. Rubin - Officer Option exercise Common Stock 3,383 $6.57 $22K
Apr 1, 2026 PR Paul D. Rubin - Officer Open-market sale Common Stock 8,820 $17.81 $157K
Apr 1, 2026 PR Paul D. Rubin - Officer Option exercise Stock Option (Right to Buy) 5,437 $0.00 -
Apr 1, 2026 PR Paul D. Rubin - Officer Option exercise Stock Option (Right to Buy) 3,383 $0.00 -
Mar 2, 2026 PR Paul D. Rubin - Officer Open-market sale Common Stock 7,433 $20.30 $151K
Mar 2, 2026 PR Paul D. Rubin - Officer Option exercise Stock Option (Right to Buy) 5,433 $0.00 -
Mar 2, 2026 PR Paul D. Rubin - Officer Option exercise Stock Option (Right to Buy) 2,000 $0.00 -
Mar 2, 2026 PR Paul D. Rubin - Officer Option exercise Common Stock 5,433 $4.11 $22K
Mar 2, 2026 PR Paul D. Rubin - Officer Option exercise Common Stock 2,000 $6.57 $13K
Mar 1, 2026 DG Dov A. Md Goldstein - Officer Option exercise Stock Option (Right to Buy) 3,542 $0.00 -
Feb 17, 2026 PR Paul D. Rubin - Officer Grant or award Stock Option (Right to Buy) 110,000 $0.00 -
Feb 17, 2026 EM Eric Morgen - Officer Grant or award Stock Option (Right to Buy) 110,000 $0.00 -
Feb 17, 2026 EM Eric Morgen - Officer Grant or award Stock Option (Right to Buy) 12,500 $0.00 -
Feb 17, 2026 DG Dov A. Md Goldstein - Officer Grant or award Stock Option (Right to Buy) 110,000 $0.00 -
Feb 17, 2026 KF Kristen Fortney - Officer Grant or award Stock Option (Right to Buy) 330,000 $0.00 -
Feb 17, 2026 SB Shane Barton - Officer Grant or award Stock Option (Right to Buy) 45,000 $0.00 -
Feb 2, 2026 PR Paul D. Rubin - Officer Option exercise Common Stock 5,433 $4.11 $22K
Feb 2, 2026 PR Paul D. Rubin - Officer Option exercise Common Stock 2,000 $6.57 $13K
Feb 2, 2026 PR Paul D. Rubin - Officer Open-market sale Common Stock 7,433 $18.75 $139K
Feb 2, 2026 PR Paul D. Rubin - Officer Option exercise Stock Option (Right to Buy) 5,433 $0.00 -
Feb 2, 2026 PR Paul D. Rubin - Officer Option exercise Stock Option (Right to Buy) 2,000 $0.00 -
Feb 1, 2026 DG Dov A. Md Goldstein - Officer Option exercise Stock Option (Right to Buy) 3,541 $0.00 -
Jan 16, 2026 DG Dov A. Md Goldstein - Officer Option exercise Stock Option (Right to Buy) 3,542 $0.00 -
Jan 13, 2026 DG Dov A. Md Goldstein - Officer Option exercise Stock Option (Right to Buy) 27,000 $0.00 -
Jan 13, 2026 KF Kristen Fortney - Officer Open-market sale Common Stock 233,107 $18.12 $4.22M
Dec 4, 2025 PR Paul D. Rubin - Officer Option exercise Common Stock 68,897 $4.11 $283K
Dec 4, 2025 PR Paul D. Rubin - Officer Open-market sale Common Stock 68,897 $10.19 $702K
Dec 4, 2025 PR Paul D. Rubin - Officer Option exercise Stock Option (Right to Buy) 68,897 $0.00 -
Jun 5, 2025 JH James Healy Grant or award Stock Option (Right to Buy) 22,000 $0.00 -
Dec 18, 2024 SB Shane Barton - Officer Grant or award Stock Option (Right to Buy) 40,000 $0.00 -
$BMY
BRISTOL MYERS SQUIBB CO
$CORT
CORCEPT THERAPEUTICS INC
